Definium says LSD-based DT120 eases generalized anxiety in late-stage trial
Definium Therapeutics said its LSD-based DT120 reduced symptoms of generalized anxiety disorder in a second successful late-stage study.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.